GlassScriptPhysician profile
Steven C Meyer
NPI 1215000302
$545,164.17
in general payments reported to CMS, 2019-2025
19 companies · $16K in 2025
The $16K reported for 2025 was more than what 76% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154K · 2020: $121K · 2021: $104K · 2022: $107K · 2023: $36K · 2024: $8,085 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $48K · Food and Beverage: $5,187 · Travel and Lodging: $4,607 · Consulting Fee: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $48,443.62 |
| Food and Beverage | $5,186.58 |
| Travel and Lodging | $4,606.76 |
| Consulting Fee | $1,580.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $453,275.00 | 2019-2023 | Precept, Acp, Brigade |
| Si-Bone, INC. | $38,190.65 | 2019-2025 | |
| Surgalign Spine Technologies, INC. | $23,340.82 | 2021-2022 | |
| Xtant Medical INC | $15,732.89 | 2024-2025 | |
| Curiteva, INC. | $3,371.14 | 2023-2025 | |
| Globus Medical, INC. | $2,884.19 | 2019-2025 | Elsa, Cohere, Acp |
| Mml US, INC. | $2,698.23 | 2022-2025 | Reactiv8 |
| Osteocentric Technologies, INC. | $1,879.93 | 2023-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Elite Orthopedics, LLC | $1,549.25 | 2024-2025 | |
| Arthrex, INC. | $987.70 | 2024 | |
| Ctl Medical Corporation | $838.20 | 2019 | |
| Cerapedics INC. | $187.37 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $93.72 | 2019-2020 | |
| Alphatec Spine, INC | $46.99 | 2019 | |
| Pacira Therapeutics, INC. | $25.88 | 2019-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $23.32 | 2025 | |
| Providence Medical Technology, INC. | $22.37 | 2025 | |
| Boston Scientific Corporation | $16.52 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.